Ashley Roberts
AstraZeneca oncology R&D executive vice-president José Baselga said: “Trastuzumab deruxtecan has the potential to transform the treatment landscape for patients with HER2-positive metastatic breast cancer who have limited treatment options today. “This priority review draws on the strength and the c...
The National Cancer Institute has given grants to 31 researchers, and a 32nd grant awaits final approval. BETHESDA, MdPurchasers of the US Postal Services breast cancer awareness stamp have funded $6.7 million in 2-year grants to support novel and innovative research into the disease. T...
Four researchers from the USA Health Mitchell Cancer Institute and the Frederick P. Whiddon College of Medicine at the University of South Alabama recently were awarded grants from the Breast Cancer Research Foundation of Alabama (BCRFA). Presented during an event in Birmingham last December, the a...
Molecular profiling guides precision treatment of breast cancer; however, Asian patients are underrepresented in publicly available large-scale studies. We established a comprehensive multiomics cohort of 773 Chinese patients with breast cancer and systematically analyzed their genomic, transcriptomic, proteomic...
FDA grants breakthrough device designation for Datar Cancer Genetics’ blood test to detect early-stage breast cancer.
Concordance of treatment recommendations for metastatic non-small-cell lung cancer between Watson for oncology system and medical team. Cancer Manag Res. 2020;12:1947. Article PubMed PubMed Central Google Scholar Download references Funding This work was supported by grants from the Watson for ...
Research into a hard-to-treat breast cancer could lead to better treatmentAbout the Innovation GrantsHealthcarepapers
TNBC is a heterogeneous subtype of breast cancer, and only a subset of TNBC can be established as PDXs. Here, we show that there is an engraftment bias toward TNBC with low levels of immune cell infiltration. Additionally, TNBC that failed to engraft sho
State implementation of the Breast and Cervical Cancer Prevention and Treatment Act of 2000: a collaborative effort among government agencies. The National Breast and Cervical Cancer Early Detection Program (NBCCEDP), administered by the Centers for Disease Control and Prevention through grants to... ...